NeuroOne Medical Technologies Corporation Insider Trading

NMTC

Last 12 months

Insiders bought 737K and sold 55K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Market Development Director Mark Christianson sold 32K on Jun 30, 33% of their stake, outside a plan.

Net open-market

+682K

2 buys · 4 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 1

executives and directors

Last open-market buy

Aug 2026

Aug 27, 2026

Get an email when NMTC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 27	David J. Wambeke Chief Business Officer	Bought	33,333	$2.01	67K	20%	Form 4
Jun 30	Mark Christianson Market Development Director	SoldNo plan	10,000	$3.18	32K	33%	Form 4
Mar 30	Mark Christianson Business Development Director	SoldNo plan	15,363	$0.74	11K	7.2%	Form 4
Mar 12 – 13	Mark Christianson Business Development Director	SoldNo plan 2 parts	917	$0.80 average	$734	0.4%	Form 4
Mar 10 – 11	Mark Christianson Business Development Director	SoldNo plan 2 parts	13,720	$0.80 average	11K	6.0%	Form 4
Mar 1	David J. Wambeke Chief Business Officer	Bought	1,000,000	$0.67	670K	New	Form 4
Sep 5, 2025	Mark Christianson Business Development Director	SoldNo plan	30,000	$0.74	22K	11%	Form 4
Jun 4, 2025	Mark Christianson Business Development Director	SoldNo plan	10,000	$0.58	6K	3.7%	Form 4
May 21, 2025 – May 22, 2025	Mark Christianson Business Development Director	SoldNo plan 2 parts	8,981	$0.62 average	6K	3.2%	Form 4
May 19, 2025 – May 20, 2025	Mark Christianson Business Development Director	SoldNo plan 2 parts	11,019	$0.67 average	7K	3.8%	Form 4
Apr 4, 2025	Ronald W. McClurg Chief Financial Officer	Bought	200,000	$0.50	100K	82%	Form 4
Apr 4, 2025	David A Rosa CEO and President	Bought	100,000	$0.50	50K	9.4%	Form 4

Aug 27
David J. Wambeke
Chief Business Officer · bought 33,333 at $2.01
67K
20% of stake
Jun 30No plan
Mark Christianson
Market Development Director · sold 10,000 at $3.18
32K
33% of stake
Mar 30No plan
Mark Christianson
Business Development Director · sold 15,363 at $0.74
11K
7.2% of stake
Mar 12 – 13No plan
Mark Christianson
Business Development Director · sold 917 at avg $0.80
$734
0.4% of stake
Mar 10 – 11No plan
Mark Christianson
Business Development Director · sold 13,720 at avg $0.80
11K
6.0% of stake
Mar 1
David J. Wambeke
Chief Business Officer · bought 1,000,000 at $0.67
670K
New position
Sep 5, 2025No plan
Mark Christianson
Business Development Director · sold 30,000 at $0.74
22K
11% of stake
Jun 4, 2025No plan
Mark Christianson
Business Development Director · sold 10,000 at $0.58
6K
3.7% of stake
May 21, 2025 – May 22, 2025No plan
Mark Christianson
Business Development Director · sold 8,981 at avg $0.62
6K
3.2% of stake
May 19, 2025 – May 20, 2025No plan
Mark Christianson
Business Development Director · sold 11,019 at avg $0.67
7K
3.8% of stake
Apr 4, 2025
Ronald W. McClurg
Chief Financial Officer · bought 200,000 at $0.50
100K
82% of stake
Apr 4, 2025
David A Rosa
CEO and President · bought 100,000 at $0.50
50K
9.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NMTC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with NMTC

CompareIntrinsic value

MDNCMedinotec Inc.

No recent price65

NSPRInspireMD Inc.

$0.78+18.33%25

XAIRBeyond Air, Inc.

$2.33+0.43%30

NXGLNexGel Inc.

$4.01-10.49%30

IVFINVO Fertility, Inc.

$2.05+5.67%40

ALURAllurion Technologies Inc.

$0.02+0.00%10

ECIAEncision Inc.

$0.03+160.87%14

PMIPicard Medical, Inc.

$7.19-7.58%30

Spot a number that looks wrong? Check it in NMTC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NMTC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.